Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes and established CVD


You May Also Like

Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans

MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) ...

Nuritas Announces Formation of Scientific Advisory Board

DUBLIN, Ireland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nuritas, a biotechnology company discovering life-changing ...